Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OTC denture cushion classification as low-risk devices sought by Mentholatum.

This article was originally published in The Tan Sheet

Executive Summary

OTC DENTURE CUSHION SAFETY CONCERNS "NOT APPLICABLE" if the products are used as a temporary fix until a dentist can be seen, Mentholatum argued in a July 26 petition requesting that FDA reclassify the over-the-counter devices from Class III (high risk) to Class I (lowest risk). The petition was submitted in response to FDA's July 11 proposal calling for premarket approval applications for OTC denture cushions or pads and repair kits ("The Tan Sheet" July 17, p. 20).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS084153

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel